Literature DB >> 25260691

The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Tarik el Scheich1, Martha C Holtfreter, Hendrik Ekamp, Daman D Singh, Rodrigo Mota, Christoph Hatz, Joachim Richter.   

Abstract

The aim of this study is to review the worldwide acceptance of the World Health Organization (WHO) ultrasound protocol for assessing hepatosplenic morbidity due to Schistosoma mansoni since its publication in 2000. A PubMed literature research using the keywords "schistosomiasis and ultrasound," "schistosomiasis and ultrasonography," and "S. mansoni and ultrasound" from 2001 to 2012 was performed. Case reports, reviews, reports on abnormalities due to parasites other than S. mansoni, organ involvement other than the human liver, and reports where ultrasound method was not described were excluded. Six studies were retrieved from other Brazilian sources. Sixty studies on 37,424 patients from 15 countries were analyzed. The WHO protocol was applied with increasing frequency from 43.75% in the years 2001 to 2004 to 84.61% in 2009 to 2012. Results obtained using the pictorial image pattern approach of the protocol are reported in 38/41 studies, whereas measurements of portal branch walls were applied in 19/41 and results reported in 2/41 studies only. The practical usefulness of the pictorial approach of the WHO protocol is confirmed by its wide acceptance. This approach alone proved satisfactory in terms of reproducibility, assessment of evolution of pathology, and comparability between different settings. The measurements of portal branches, also part of the protocol, may be omitted without losing relevant information since results obtained by these measurements are nonspecific. This would save resources by reducing the time required for each examination. It is also more feasible for examiners who are not specialized in medical imaging. As with all protocols, incipient liver fibrosis is difficult to distinguish from normal ultrasound findings of the liver. The ability of this protocol to predict complications in severe cases should be further evaluated in a higher number of patients.

Entities:  

Mesh:

Year:  2014        PMID: 25260691     DOI: 10.1007/s00436-014-4117-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  86 in total

1.  Schistosoma mansoni: magnetic resonance analysis of liver fibrosis according to WHO patterns for ultrasound assessment of schistosomiasis-related morbidity.

Authors:  Luciana C S Silva; Luciene M Andrade; Leonardo C de Queiroz; Izabela Voieta; Letícia M Azeredo; Carlos M F Antunes; José R Lambertucci
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-07       Impact factor: 2.743

2.  Comparative clinical and ultrasound study of egg-negative and egg-positive individuals from Schistosoma mansoni low morbidity endemic areas, and hospitalized patients with hepatosplenic disease.

Authors:  Telcia V B Magalhães; Giovanni Gazzinelli; Maria Carolina B Alvarez; F C Lima e Silva; Lucia Alves Oliveira Fraga; Alda Maria S Silveira; Andrea Gazzinelli; Jeffrey Bethony; Philip LoVerde; Iramaya R Caldas; Rodrigo Correa-Oliveira; Aluízio Prata
Journal:  Rev Soc Bras Med Trop       Date:  2005-01-18       Impact factor: 1.581

3.  Ultrasonography of periportal fibrosis in schistosomiasis mansoni in Brazil.

Authors:  R Gerapacher-Lara; R A Pinto-Silva; A A Rayes; S C Drummond; J R Lambertucci
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 May-Jun       Impact factor: 2.184

4.  Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.

Authors:  L F Alves Oliveira; E C Moreno; G Gazzinelli; O A Martins-Filho; A M S Silveira; A Gazzinelli; L C C Malaquias; P LoVerde; P Martins Leite; R Correa-Oliveira
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Clinical versus ultrasound examination in the evaluation of hepatosplenic schistosomiasis mansoni in endemic areas.

Authors:  Carolina Coimbra Marinho; Izabela Voieta; Letícia Martins Azeredo; Marina Pires Nishi; Thaís Sanai Batista; Ana Carolina Figueiredo Pereira; José Carlos Serufo; Leonardo Campos de Queiroz; Raiza Ruiz-Guevara; Carlos Maurício Antunes; Aluízio Prata; José Roberto Lambertucci
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-09       Impact factor: 2.743

6.  Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.

Authors:  M A Homeida; I el Tom; T Nash; J L Bennett
Journal:  Am J Trop Med Hyg       Date:  1991-09       Impact factor: 2.345

7.  Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.

Authors:  Shona Wilson; Birgitte J Vennervald; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Mark Booth; H Curtis Kariuki; Joseph K Mwatha; Gachuhi Kimani; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Trop Med Int Health       Date:  2007-12       Impact factor: 2.622

8.  Gammaglutamyl transpeptidase activity in patients with schistosomiasis.

Authors:  Mohammad Abdullah Al Mofarreh; Ahmed Yahia Al Akwaa; Ibrahim Abdulkarim Al Mofleh
Journal:  Saudi J Gastroenterol       Date:  2003-01       Impact factor: 2.485

9.  Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoni.

Authors:  Shona Wilson; Birgitte J Vennervald; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Mark Booth; H Curtis Kariuki; Joseph K Mwatha; Gachuhi Kimani; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-10-08       Impact factor: 2.184

10.  Evaluation of schistosoma mansoni morbidity one year after praziquantel treatment in rhino cAMP and obongi in west nile, Uganda.

Authors:  E I Odongo-Aginya; T L Lakwo; Med Ekkehard Doehring
Journal:  Afr J Infect Dis       Date:  2010
View more
  14 in total

1.  Application of Ultrasonography in the Diagnosis of Infectious Diseases in Resource-Limited Settings.

Authors:  Enrico Brunetti; Tom Heller; Joachim Richter; Daniel Kaminstein; Daniel Youkee; Maria Teresa Giordani; Samuel Goblirsch; Francesca Tamarozzi
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

2.  Schistosoma haematobium in Guinea-Bissau: unacknowledged morbidity due to a particularly neglected parasite in a particularly neglected country.

Authors:  Monica C Botelho; Ana Machado; André Carvalho; Manuela Vilaça; Orquídea Conceição; Fernanda Rosa; Helena Alves; Joachim Richter; Adriano Agostinho Bordalo
Journal:  Parasitol Res       Date:  2016-01-12       Impact factor: 2.289

3.  Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya.

Authors:  Stephanie M Davis; Ryan E Wiegand; Fridah Mulama; Edmund Ireri Kareko; Robert Harris; Elizabeth Ochola; Aaron M Samuels; Fredrick Rawago; Pauline M Mwinzi; LeAnne M Fox; Maurice R Odiere; Kimberly Y Won
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

4.  The burden, pattern and factors that contribute to periportal fibrosis in HIV-infected patients in an S. mansoni endemic rural Uganda.

Authors:  Ponsiano Ocama; Kenneth Christopher Opio; Emmanuel Seremba; Paul Ajal; Betty Stephanie Apica; Emmanuel Odongo Aginya
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

5.  The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Systematic review.

Authors:  Robert Akpata; Andreas Neumayr; Martha C Holtfreter; Ingela Krantz; Daman D Singh; Rodrigo Mota; Susanne Walter; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2015-02-25       Impact factor: 2.289

Review 6.  Point-of-Care Ultrasound Assessment of Tropical Infectious Diseases--A Review of Applications and Perspectives.

Authors:  Sabine Bélard; Francesca Tamarozzi; Amaya L Bustinduy; Claudia Wallrauch; Martin P Grobusch; Walter Kuhn; Enrico Brunetti; Elizabeth Joekes; Tom Heller
Journal:  Am J Trop Med Hyg       Date:  2015-09-28       Impact factor: 2.345

Review 7.  Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

Authors:  Francesca Tamarozzi; Veronica A Fittipaldo; Hans Martin Orth; Joachim Richter; Dora Buonfrate; Niccolò Riccardi; Federico G Gobbi
Journal:  PLoS Negl Trop Dis       Date:  2021-03-25

8.  Is ultrasonography useful for population studies on schistosomiasis mansoni? An evaluation based on a survey on a population from Kome Island, Tanzania.

Authors:  Mats Sl Asztely; Bo Eriksson; Reverianus M Gabone; Lars-Åke Nilsson
Journal:  Acta Radiol Open       Date:  2016-12-01

9.  Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium.

Authors:  Chalotte Willemann Stecher; Henry Madsen; Shona Wilson; Moussa Sacko; Christian Wejse; Adama D Keita; Aly Landouré; Mamadou S Traoré; Per Kallestrup; Eskild Petersen; Birgitte Vennervald
Journal:  Heliyon       Date:  2017-11-14

10.  Liver ultrasound elastography for the evaluation of periportal fibrosis in schistosomiasis mansoni: A cross-sectional study.

Authors:  Joelma Carvalho Santos; Andrea Dória Batista; Carla Maria Mola Vasconcelos; Roberto Souza Lemos; Valter Romão de Souza Junior; Alain Dessein; Hélia Dessein; Silvia Maria Lucena Montenegro; Edmundo Pessoa Almeida Lopes; Ana Lúcia Coutinho Domingues
Journal:  PLoS Negl Trop Dis       Date:  2018-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.